J. Mark Sloan, MD

Associate Professor, Medicine

J. Sloan
617.638.7520
820 Harrison Ave

Biography

Factotum hematologist at Boston Medical Center
Associate Professor at Boston University School of Medicine.
Program director for the hematology/oncology fellowship at Boston University.
I see patients with a variety of benign and malignant blood disorders.
I have particular research interests in AL Amyloidosis, HTLV-1 associated leukemia/lymphoma (ATLL)

Other Positions

  • Member, BU-BMC Cancer Center, Boston University
  • Member, Amyloidosis Center, Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Education

  • Yale University School of Medicine, MD
  • Harverford College, BS

Publications

  • Published on 6/22/2022

    Gustine JN, Staron A, Szalat RE, Mendelson LM, Joshi T, Ruberg FL, Siddiqi O, Gopal DM, Edwards CV, Havasi A, Kaku M, Lau KHV, Berk JL, Sloan JM, Sanchorawala V. Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study. Am J Hematol. 2022 Jun 22. PMID: 35731907.

    Read at: PubMed
  • Published on 3/9/2022

    Hughes DM, Henshaw L, Blevins F, Edwards C, Lerner A, Sloan JM, Sanchorawala V. Standard 30-minute Monitoring Time and Less Intensive Pre-medications is Safe in Patients Treated With Subcutaneous Daratumumab for Multiple Myeloma and Light Chain Amyloidosis. Clin Lymphoma Myeloma Leuk. 2022 Aug; 22(8):566-568. PMID: 35367193.

    Read at: PubMed
  • Published on 2/25/2022

    Milrod CJ, Mann M, Blevins F, Hughes D, Patel P, Li KY, Lerner A, Sanchorawala V, Sloan JM. Underrepresentation of Black participants and adverse events in clinical trials of lenalidomide for myeloma. Crit Rev Oncol Hematol. 2022 Apr; 172:103644. PMID: 35227897.

    Read at: PubMed
  • Published on 2/2/2022

    Gupta VK, El-Jawahri A, Orkev G, Johnson MH, Weinberg J, Goodrich C, Janakiram M, Sloan JM. Impact of Human T Cell Lymphotropic Virus Type 1 and 2 Infection on Survival Following Stem Cell Transplantation. Transplant Cell Ther. 2022 May; 28(5):276.e1-276.e5. PMID: 35123118.

    Read at: PubMed
  • Published on 11/29/2021

    Furtado VF, Brauneis D, Weinberg J, Elhassan N, Sloan JM, Sanchorawala V. Early serum free light chain response after high-dose melphalan and stem cell transplantation predicts hematologic response in AL amyloidosis. Bone Marrow Transplant. 2022 02; 57(2):306-308. PMID: 34845368.

    Read at: PubMed
  • Published on 11/15/2021

    Szalat RE, Gustine J, Sloan JM, Edwards CV, Sanchorawala V. Predictive factors of outcomes in patients with AL amyloidosis treated with daratumumab. Am J Hematol. 2022 01 01; 97(1):79-89. PMID: 34739735.

    Read at: PubMed
  • Published on 9/20/2021

    Charidimou A, Samudrala S, Cervantes-Arslanian AM, Sloan JM, Dasenbrock HH, Daneshmand A. Vaccine-Induced Immune Thrombotic Thrombocytopenia with Concurrent Arterial and Venous Thrombi Following Ad26.COV2.S Vaccination. J Stroke Cerebrovasc Dis. 2021 Dec; 30(12):106113. PMID: 34547677.

    Read at: PubMed
  • Published on 6/29/2021

    Smyth R, Sloan JM, Burks E, Hawkins F. Primary pulmonary marginal zone lymphoma: an unusual cause of pulmonary infiltrates. Respirol Case Rep. 2021 Aug; 9(8):e00806. PMID: 34221408.

    Read at: PubMed
  • Published on 5/27/2021

    Milrod CJ, Blevins F, Hughes D, Lerner A, Sarosiek S, Sanchorawala V, Sloan JM. Incidence of skin hyperpigmentation in Black patients receiving treatment with immunomodulatory drugs. Blood. 2021 05 27; 137(21):2987-2989. PMID: 33728443.

    Read at: PubMed
  • Published on 3/1/2021

    Kaufman AR, Quillen K, Distefano AG, Sloan JM. Nonsecretory Recurrence of Multiple Myeloma Presenting as Sixth Nerve Palsy Secondary to Clival Plasmacytoma. J Neuroophthalmol. 2021 03 01; 41(1):e77-e78. PMID: 32235225.

    Read at: PubMed

View 64 more publications: View full profile at BUMC

View all profiles